Fig. 4From: Cancer and COVID-19: unravelling the immunological interplay with a review of promising therapies against severe SARS-CoV-2 for cancer patientsPromising therapies against severe SARS-CoV-2. Known clinical pharmacological agents are currently being tested to assess their efficacy to combat severe SARS-CoV-2. Within the context of our proposed COVID-19 Cancer Model, their mechanism of action is being highlighted. The image of SARS-CoV-2 was derived from the Centers for Disease Control and Prevention (CDC) website: https://phil.cdc.gov/Details.aspx?pid=23312Back to article page